LifeMD, Inc. (LFMD) stock
LFMDNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMDP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3025% below fair value
$2.19+0.54 (+32.63%)
Close on Nov 13, 2026Market cap $105.80MP/E –Yield –
LifeMD pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
LifeMD's pe ratio was 423.5× on Nov 11, 2026, against 28.8× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 423.5× | +393.5 |
| 2018 | Jul 31, 2018 | 30.0× | +30.0 |
| 2016 | Jan 29, 2016 | 0.0× | +0.0 |
| 2015 | Dec 31, 2015 | 0.0× | – |
See a number that looks wrong?